Health Cor Management, L.P. Ikena Oncology, Inc. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.23 - $7.4 $218,150 - $499,788	-67,539 Reduced 23.48%	220,082 $975,000
Q4 2021 Feb 14, 2022	SELL	$10.52 - $16.96 $550,511 - $887,516	-52,330 Reduced 15.39%	287,621 $3.61 Million
Q3 2021 Nov 15, 2021	SELL	$9.82 - $15.23 $369,232 - $572,648	-37,600 Reduced 9.96%	339,951 $4.29 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $26.0 $482,218 - $944,814	36,339 Added 10.65%	377,551 $5.3 Million
Q1 2021 May 17, 2021	BUY	$25.6 - $32.0 $8.74 Million - $10.9 Million	341,212 New	341,212 $9.64 Million

30.4M

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $55.5M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.